Latest inventions in science and technology
DengiAll
▪ DengiAll – India’s first indigenous tetravalent dengue vaccine.
▪ The Indian Council of Medical Research (ICMR) and Panacea Biotec Ltd. to initiate third phase trials.
▪ Tetravalent vaccine – effective against all four serotypes of the dengue virus (1 to 4).
▪ Developer: Panacea Biotec, in collaboration with the Indian Council of Medical Research (ICMR).
▪ Funding: Primarily funded by ICMR, with partial support from Panacea Biotec.
▪ Dengue is a major public health concern in India, which ranks among the top 30 countries with the highest incidence of the disease.
▪ There is currently no antiviral treatment or licensed vaccine for dengue in India.
▪ In India, approximately 75-80% of infections are asymptomatic, yet these individuals can still transmit the infection through the bite of Aedes mosquitoes.
